Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20,250,000
-
Total 13F shares
-
1,659,323
-
Share change
-
-124,947
-
Total reported value
-
$8,461,848
-
Put/Call ratio
-
0%
-
Price per share
-
$5.10
-
Number of holders
-
22
-
Value change
-
-$813,295
-
Number of buys
-
10
-
Number of sells
-
6
Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q4 2022
As of 31 Dec 2022 enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) had 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,659,323 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., MORGAN STANLEY, ARTHUR M. COHEN & ASSOCIATES, LLC, STATE STREET CORP, and DIMENSIONAL FUND ADVISORS LP.
This table shows 22 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.